Entera Bio shareholders approve all 8 proposals at 2024 annual meeting

Entera Bio Ltd.

Elected Miranda Toledano and Yonatan Malca to three-year board terms with ~99% of votes cast.
Approved one-time CEO compensation grant for Miranda Toledano (14,365,894 for, 544,357 against).
Approved amendment to 2018 Equity Incentive Plan, increasing shares by 1,788,515 (14,131,640 for).
Ratified Kesselman & Kesselman (PwC) as independent auditors for FY2024 with overwhelming support.
Advisory vote on executive compensation passed; the most frequent frequency vote was 'one year'.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.